Pharmaceutical

Risk adjusted net present value: What is the current va...

LY-3972406 is a small molecule commercialized by Eli Lilly and Co, with a leadin...

Risk adjusted net present value: What is the current va...

PF-07275315 is a monoclonal antibody commercialized by Pfizer, with a leading Ph...

Risk adjusted net present value: What is the current va...

ELVN-002 is a small molecule commercialized by Enliven Therapeutics, with a lead...

Risk adjusted net present value: What is the current va...

NN-9931 is a recombinant peptide commercialized by Novo Nordisk, with a leading ...

Moderna pauses plans to build mRNA facility in Kenya

Moderna has announced the halt of its project to build a messenger ribonucleic a...

Fujifilm invests $1.2bn ramping up North Carolina facility

The site expansion is set to add 680 jobs to the site and expand Fujifilm’s cont...

Eliem Therapeutics agrees to acquire Tenet

Eliem Therapeutics has announced an agreement for the acquisition of development...

Novartis signs deal for Arvinas’ prostate cancer therapy

Novartis has signed an exclusive strategic licence agreement for Arvinas’ ARV-76...

FDA approves AstraZeneca’s FASENRA for asthma in children

The US FDA has granted approval for AstraZeneca's FASENRA in children aged six t...

Rallybio and J&J collaborate to tackle maternal-foetal ...

The collaboration pact will see Rallybio gaining a $6.6m equity investment from ...

UK charities condemn continued drug shortages

As the UK tackles several drug shortages, UK charities and pharmacists called fo...

FDA approves new administration routes for Xcopri 

SK Life Sciences Xcopri (cenobamate) is approved as an oral suspension mixed wit...

Candel wins FDA orphan drug designation for pancreatic ...

The FDA designation follows positive Phase II data announced recently.

Century secures $60m in stock sale and buys preclinical...

Century Therapeutics will pay $35m upfront and an additional $10m milestone paym...

Kyowa Kirin gets grant for monoclonal antibody inhibiti...

Discover the groundbreaking patent by Kyowa Kirin Co Ltd for a monoclonal antibo...

MorphoSys gets grant for novel compounds for treating d...

Discover a groundbreaking patent by MorphoSys AG for novel compounds targeting m...